RESEARCH REPORT UPDATE AMBS: AMARANTUS RECEIVES
Post# of 30027
Posted On: 09/14/2015 8:23:58 PM
RESEARCH REPORT UPDATE
AMBS: AMARANTUS RECEIVES ORPHAN DRUG DESIGNATION FROM THE FDA FOR MANF FOR THE TREATMENT OF RETINAL ARTERY OCCLUSION
09/14/2015
http://scr.zacks.com/News/Press-Releases/Pres...fault.aspx
AMBS: AMARANTUS RECEIVES ORPHAN DRUG DESIGNATION FROM THE FDA FOR MANF FOR THE TREATMENT OF RETINAL ARTERY OCCLUSION
09/14/2015
http://scr.zacks.com/News/Press-Releases/Pres...fault.aspx
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼